F694 in New York. Pick another state for the same tag.
Against expectation — 2025
New York cites F694 less often than its own record predicts
Versus expected share0.91×
0.91 times the national share — cited less often here than elsewhere.
Share of New York citations0.29%
Of every deficiency written in New York in 2025, this is the portion that was F694.
New York0.29%
National0.32%
Share of all citations that were F694.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New York surveyors wrote
F694 findings written in New York, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
E · No harm, potential for more than minimal, patternJuly 10, 2026
Based on observation, record review, and interviews (iQIES Intake 3009492) the facility failed to ensure intravenous (through a vein) medications were administered consistent with professional standards of practice and in accordance with physician orders for two of two residents (Residents #122 and #124) reviewed. Specifically, Resident #124's intravenous Zosyn (antibiotic) was not administered timely; their vancomycin (antibiotic) was administered at an incorrect concentration and rate; the provider was not notified of an infiltration (leakage into surrounding tissue) of the resident's intravenous vancomycin; and their intravenous line was not capped when the resident left the facility for an appointment. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction